Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Telso AD_Sopharma_rights_5years_EN_26012026.pdfNotification from "Telso" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000002262

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 62 / 2026
Date of issue: 2026-01-29
Short name of the issuer
SOPHARMA AD
Subject
Notification from "Telso" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000002262
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Notification from "Telso" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000002262
Annexes
File Description
Telso AD_Sopharma_rights_5years_EN_26012026.pdf
Telso AD_Sopharma_rights_5years_EN_26012026.pdf		 Notification from "Telso" AD under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000002262

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-01-29 Ognian Ivanov Donev Executive Director
20260129_114942_1886498228_Telso_AD_Sopharma_rights_5years_EN_26012026.pdf

Pobierz